Thrombospondin-1 and Pigmented Epithelium Derived Factor Levels in Patients With Diabetes Mellitus.

Completed

Conditions studied: Diabetes, Diabetes Mellitus

In brief

You are being asked to be in a research study to determine blood levels and vitreous levels of compounds called thrombospondin 1 (TSP1) and pigment epithelium derived factor (PEDF). These compounds exists naturally in your body.

Key facts

Study ID

NCT01809093

Run by

MidAtlantic Retina

People needed

90

Starts

2010-03-01

Expected to finish

2014-03-01

Last updated by the study team

2017-02-23

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Ability to provide written informed consent and comply with study assessments for the full duration of the study
• Diabetes Mellitus
• Undergoing pars plana vitrectomy for any reason

You may not qualify if…

• Use of any anti-VEGF (vascular endothelial growth factor ) medications

Where it is running

• Mid Atlantic Retina- Wills Eye Institute — Philadelphia, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.